Chuck Bryant

And again, these limits are like the amount that we're getting shouldn't harm like, you know, children and adults.

Yeah, that's weird.

All right, Dr. Clark, we're going to take a break and ponder that, and we'll be right back with more on BPAs.

I gotta say, I'm very impressed.

But I called you a doctor.

All right.

So in the United States, the FDA is who is in charge of regulating the BPA use.

And in 2010, they did a four-year review of BPA studies, which resulted in 2014, basically saying, you know what?

We're upholding our previous no-observe adverse effects label.

As long as you don't get more than five milligrams of

a body weight per kilogram of body weight per day, you'll be fine.

Well, that's what they say.

I mean, we should talk about some of the things, though.

I know you mentioned a few things, but let me see here.

Type 2 diabetes, potentially in adults, insulin resistance in children and adults, polycystic ovary syndrome, obesity and hypertension in children and adults.

Yeah, for sure.

Europe, of course, is leading the way in front of us.

In April, just a few years ago in 2023, their FDA, which is the European Food Safety Authority, said, all right, we've seen the research.

And I think they lowered their safe level a lot, I think, to 0.2 nanograms, which is two billionths of a gram or 0.2 billionths of a gram.

Right.